Judge Denies Humana's Challenge to CMS 2025 Medicare Advantage Ratings
A U.S. court rejected Humana's attempt to contest the CMS 2025 Medicare Advantage ratings, affecting Humana's bonus payments and highlighting CMS's regulatory role.
A U.S. court rejected Humana's attempt to contest the CMS 2025 Medicare Advantage ratings, affecting Humana's bonus payments and highlighting CMS's regulatory role.
Freedom Health agreed to pay $31.7M to settle allegations of False Claims Act violations relating to Medicare Advantage payment schemes. The settlement underscores regulatory enforcement in managed care and Medicare compliance.
Medicare Advantage expansion is linked to care delays in skilled nursing facilities, urging providers to better understand MA protocols for improved patient outcomes.
Medicare audits are becoming more frequent and aggressive, leading to inflated repayment demands. Learn how statistical challenges, independent coding reviews, and specialty expertise can protect healthcare providers from exaggerated audit outcomes.
The August 2025 OIG report analyzes Medicare billing for remote patient monitoring services, highlighting fraud risks and compliance recommendations amid rising RPM usage.
Elevance Health and leading insurers recalibrate Medicare Advantage plans and Part D coverage amid rising costs and regulatory shifts, focusing on risk management and compliance.
The DOJ is broadening its investigation of UnitedHealth Group, examining prescription management practices at Optum Rx and physician reimbursement methods amid concerns beyond Medicare fraud.
The 2025 J.D. Power Medicare Advantage Study identifies declining member satisfaction and highlights how digital onboarding and transparency improve member trust across U.S. Medicare Advantage plans.
CMS extends the Medicare off-cycle revalidation deadline for skilled nursing facilities to January 1, 2026, maintaining the existing requirements. Providers should prepare to comply to avoid Medicare participation disruptions.
US government pursues civil forfeiture against two Florida DME companies accused of over $33 million in fraudulent Medicare claims for medically unnecessary equipment and services.